Ignite Creation Date:
2024-05-05 @ 9:43 PM
Last Modification Date:
2024-10-26 @ 10:09 AM
Study NCT ID:
NCT00956982
Status:
UNKNOWN
Last Update Posted:
2009-08-11
First Post:
2009-08-06
Brief Title:
PEG-IFN Plus Ribavirin Combination Therapy for Older Patients
Sponsor:
Kyushu University
Organization:
Kyushu University
Study Overview
Official Title:
Pegylated Interferon Alpha-2b Plus Ribavirin Combination Treatment for Older Patients With Chronic Hepatitis C
Status:
UNKNOWN
Status Verified Date:
2009-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to analyze the efficacy and safety of a combination therapy of pegylated interferon PEG-IFN alpha-2b plus ribavirin RBV for older Japanese patients 65years old infected with hepatitis C virus HCV compared with younger patients 65 years old
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None